Previous studies have demonstrated the significant upregulation of NFS-1 in lung cancer tissues and its ability to effectively mitigate hyperoxia-induced ferroptosis in lung cancer cells, its potential as a protective agent against ferroptosis in this context [24]. This evidence concerns the gene NFS1 and lung carcinoma.